Transgender chemsex study aims to build safer spaces

NCT ID NCT07505875

Recruiting now Knowledge-focused Sponsor: Institute of HIV Research and Innovation Foundation, Thailand Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study interviews 50 transgender adults in Thailand about their chemsex behaviors—reasons, patterns, and impacts—along with stigma and HIV prevention needs. Researchers also gather input from stakeholders to identify barriers and facilitators for creating transgender-friendly harm reduction services. The goal is to inform future programs that better support this community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could guide the creation of transgender-specific harm reduction services for chemsex, improving health outcomes.
What could go wrong: This is a small, early-stage observational study with only 50 participants in Thailand, so findings may not apply broadly or lead to immediate changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chemsex Harm Reduction sexually transmitted disease substance abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION SEXUALLY TRANSMITTED INFECTIONS (STIS) SUBSTANCE USE

Contacts and locations

Locations

Tangerine Clinic, Institute of HIV Research and Innovation
RECRUITING

Pathum Wan, Bangkok, 10330, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.